# Spontaneous recovery from post‐COVID‐19 brain fog

**Authors:** Teruaki Hayashi, Masaaki Iwata

PMC · DOI: 10.1002/pcn5.169 · PCN Reports: Psychiatry and Clinical Neurosciences · 2024-01-24

## TL;DR

A man experienced brain fog after recovering from COVID-19, but his cognitive function improved over time without medication.

## Contribution

This case report highlights spontaneous recovery from post-COVID-19 brain fog, emphasizing the importance of long-term monitoring.

## Key findings

- The patient's cognitive function improved over 11 months without medication.
- Initial tests showed no abnormalities, but cognitive decline was suspected.
- Symptoms of brain fog resolved spontaneously, suggesting potential for recovery.

## Abstract

One‐third of individuals who contract novel coronavirus disease 2019 (COVID‐19) reportedly experience persistent symptoms, including respiratory issues, headache, dizziness, taste disorders, fatigue, and various psychiatric and neurological symptoms, known as post‐acute sequelae of SARS‐CoV‐2. In this case report, we present a patient who became aware of brain fog, which is cognitive impairment, approximately 2 months after their COVID‐19 symptoms had resolved, accompanied by anxiety and depression.

The patient, a 35‐year‐old Japanese man, was infected with COVID‐19 and resumed work approximately 2 weeks later after symptoms improved. Approximately 1 month after returning to work, the patient's concentration became impaired and he started making noticeable errors at work. These symptoms did not improve, leading him to the outpatient clinic specializing in COVID‐19 sequelae at our hospital. Here, he underwent blood tests, electroencephalography, and head magnetic resonance imaging, which did not reveal any abnormalities. Cognitive decline due to COVID‐19 sequelae was therefore suspected, prompting his evaluation in our department approximately 5 months after his initial COVID‐19 infection. Detailed cognitive function tests were performed. He was monitored without the use of medications, and his cognitive function gradually improved. Approximately 11 months after his initial COVID‐19 infection, the same cognitive function tests were conducted again, because his subjective cognitive function symptoms had disappeared, and improvement was observed in many items.

Since brain fog is a relatively common sequela, we emphasize the importance of keeping this in mind from the initial consultations and comparing results over time.

## Full-text entities

- **Diseases:** headache (MESH:D006261), taste disorders (MESH:D013651), brain fog (MESH:D005222), infected (MESH:D007239), fatigue (MESH:D005221), Cognitive decline (MESH:D003072), depression (MESH:D003866), anxiety (MESH:D001007), post-acute sequelae of SARS-CoV-2 (MESH:D000094024), dizziness (MESH:D004244), COVID-19 (MESH:D000086382), psychiatric and neurological symptoms (MESH:D001523)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11114291/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC11114291/full.md

---
Source: https://tomesphere.com/paper/PMC11114291